Women Less Likely to Be Full Professors Than Men

Share this content:
Women Less Likely to Be Full Professors Than Men
Women Less Likely to Be Full Professors Than Men

WEDNESDAY, Sept. 16, 2015 (HealthDay News) -- In academic medicine, women are less likely to be full professors than men and have less startup funding than men, according to two studies published in the Sept. 15 issue of JAMA.

Anupam B. Jena, M.D., Ph.D., from Harvard Medical School in Boston, and colleagues used a cross-sectional database to examine sex differences in faculty rank among U.S. academic physicians. The researchers identified 30,464 women who were medical faculty versus 60,609 men. Overall, 11.9 and 28.6 percent of women and men, respectively, had full-professor appointments; after multivariable adjustment, women were less likely to have achieved full-professor status than men. Sex differences in full professorship were seen across all specialties.

Robert Sege, M.D., Ph.D., from Health Resources in Action in Boston, and colleagues compared support for male and female grant applicants using application data from two New England biomedical research programs. The researchers found that men reported significantly higher startup support than women (median $889,000 versus $350,000). Support of more than $1 million was reported by 51 men and 11 women (40 versus 12 percent). Men had higher support regardless of degree, but a statistically significant difference was seen only for those with PhDs. Significantly more startup support was reported by men than women in basic sciences.

"This first look suggests the need for systematic study of sex differences in institutional support and the relationship to career trajectories," Sege and colleagues write.

Abstract -- Jena
Full Text (subscription or payment may be required)
Abstract -- Sege
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »